Featured Research

from universities, journals, and other organizations

Doctors look at treating specific types of pediatric cancer with viral therapy

Date:
September 9, 2013
Source:
Nationwide Children's Hospital
Summary:
Parents do everything they can to protect their children against all of the nasty germs floating around classrooms this time of year. Doctors and researchers, however, are looking into how those same types of common viruses can actually help treat a child who is diagnosed with certain cancers.

Parents do everything they can to protect their children against all of the nasty germs floating around classrooms across the country this time of year. Doctors and researchers at Nationwide Children's Hospital, however, are looking into how those same types of common viruses can actually help treat a child who is diagnosed with certain cancers.

This novel approach is called, viral therapy. It involves slightly altering a virus in the laboratory, injecting it directly into a solid cancer tumor which then causes the tumor to shrink and disappear altogether.

Several years of study into this approach have led scientists to find more and more evidence that oncolytic viruses show promise as anticancer agents with variations of the herpes simplex virus (HSV) among the most commonly used. Viral therapy has been studied in adults, but only a few institutions have studied it in kids.

"Virus therapy is a very promising area of cancer treatment," said Timothy Cripe, MD, PhD, division chief of Hematology/Oncology and Bone Marrow Transplantation at Nationwide Children's. "By injecting the tumor directly with a virus, it will cause the body's immune system to react and attack that tumor while preserving the body's healthy cells."

For the damage that the virus does to the tumor, it does not have any effect on the healthy tissue surrounding the tumor and cells throughout the body. That means there are very few, if any, side effects from the treatment. Further, viral therapy could make a world of difference for pediatric cancer patients that would otherwise be treated with chemotherapy. Those patients would not have to experience the common side effects from chemo including hair loss, fatigue, nausea and weight loss/gain.

Dr. Cripe and his team will soon launch a phase I clinical trial at Nationwide Children's which will study viral therapy for solid cancer tumors in kids. They will be looking at this treatment for cancers such as neuroblastoma and sarcoma.

In March earlier this year, Dr. Cripe, also a faculty member at The Ohio State University College of Medicine, and his team published findings in Molecular Therapy which shed additional light on how viral therapy combined with drugs that attack the tumor blood vessels and simultaneously selectively suppress the immune response within the cancer could be more effective against treating solid tumors.


Story Source:

The above story is based on materials provided by Nationwide Children's Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mark A Currier, Francis K Eshun, Allyson Sholl, Artur Chernoguz, Kelly Crawford, Senad Divanovic, Louis Boon, William F Goins, Jason S Frischer, Margaret H Collins, Jennifer L Leddon, William H Baird, Amy Haseley, Keri A Streby, Pin-Yi Wang, Brett W Hendrickson, Rolf A Brekken, Balveen Kaur, David Hildeman, Timothy P Cripe. VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells. Molecular Therapy, 2013; 21 (5): 1014 DOI: 10.1038/mt.2013.39

Cite This Page:

Nationwide Children's Hospital. "Doctors look at treating specific types of pediatric cancer with viral therapy." ScienceDaily. ScienceDaily, 9 September 2013. <www.sciencedaily.com/releases/2013/09/130909201048.htm>.
Nationwide Children's Hospital. (2013, September 9). Doctors look at treating specific types of pediatric cancer with viral therapy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/09/130909201048.htm
Nationwide Children's Hospital. "Doctors look at treating specific types of pediatric cancer with viral therapy." ScienceDaily. www.sciencedaily.com/releases/2013/09/130909201048.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins